These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17112852)

  • 21. A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation.
    Farney A; Sundberg A; Moore P; Hartmann E; Rogers J; Doares W; Jarrett A; Adams P; Stratta R
    Clin Transplant; 2008; 22(1):41-9. PubMed ID: 18217904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rabbit antithymocyte globulin induction and risk of post-transplant lymphoproliferative disease in adult and pediatric solid organ transplantation: An update.
    Hertig A; Zuckermann A
    Transpl Immunol; 2015 Jun; 32(3):179-87. PubMed ID: 25936966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine.
    Knight RJ; Kerman RH; Podder H; Katz SM; Van Buren CT; Kahan BD
    Transplant Proc; 2005 Mar; 37(2):1280-2. PubMed ID: 15848695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro studies of endomyocardial biopsies from heart transplant recipients on RATG and OKT3 immunoprophylaxis protocols.
    Kaufman C; Zeevi A; Zerbe T; Kormos R; Griffith B; Hardesty R; Duquesnoy RJ
    Transplantation; 1989 Oct; 48(4):621-5. PubMed ID: 2799915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rabbit antithymocyte globulin induction therapy in adult renal transplantation.
    Hardinger KL
    Pharmacotherapy; 2006 Dec; 26(12):1771-83. PubMed ID: 17125438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies.
    Colovai AI; Vasilescu ER; Foca-Rodi A; Kim-Schulze S; Hussaini N; D'agati VD; Markowitz GS; Wang C; Cohen DJ; Hardy MA; Suciu-Foca N
    Hum Immunol; 2005 May; 66(5):501-12. PubMed ID: 15935887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor bone marrow infusion suppresses alloantibody response in RATG-treated recipients: a correlate of long survival.
    Thomas JM; Carver FM; Cunningham PR; Gross U; Verbanac KM; Rebellato LM; Riley R; Thomas FT
    Transplant Proc; 1993 Feb; 25(1 Pt 1):342-3. PubMed ID: 8438326
    [No Abstract]   [Full Text] [Related]  

  • 28. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.
    Ho EK; Vlad G; Vasilescu ER; de la Torre L; Colovai AI; Burke E; Deng M; Schwartz J; Marboe C; Mancini D; Opelz G; Suciu-Foca N
    Hum Immunol; 2011 Jan; 72(1):5-10. PubMed ID: 20971146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.
    Pennington CA; Tischer SM; Lee E; Lee S; Sindelar J; Park JM
    Pharmacotherapy; 2015 Aug; 35(8):748-54. PubMed ID: 26234282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymoglobulin dose optimization for induction therapy in high risk kidney transplant recipients.
    Gurk-Turner C; Airee R; Philosophe B; Kukuruga D; Drachenberg C; Haririan A
    Transplantation; 2008 May; 85(10):1425-30. PubMed ID: 18497682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell-specific activity in rabbit anti-human thymocyte globulin. Correlation with immunosuppresive activity in nonhuman primates.
    Thomas JM; Williams EA; Thomas FT; Millington GM
    Transplantation; 1978 Mar; 25(3):97-102. PubMed ID: 417439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes.
    Trofe-Clark J; Reese PP; Patel HJ; Jakobowski D; Goral S; Doll SL; Abt PL; Bloom RD
    Transplantation; 2012 Sep; 94(5):506-12. PubMed ID: 22895613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of small variations in the delivered dose of rabbit antithymocyte induction therapy in kidney transplantation with early corticosteroid withdrawal.
    Tsapepas DS; Mohan S; Tanriover B; Dube G; Crew RJ; Cohen DJ; Hardy MA; Sandoval PR; Ratner LE
    Transplantation; 2012 Aug; 94(4):325-30. PubMed ID: 22814328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Tiwari SC; Mehra NK
    Transplant Proc; 2004 Jun; 36(5):1336-9. PubMed ID: 15251326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modern approaches to combining sirolimus with calcineurin inhibitors.
    Stevens RB
    Transplant Proc; 2008 Dec; 40(10 Suppl):S21-4. PubMed ID: 19100901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined induction therapy with rabbit antithymocyte globulin and rituximab in highly sensitized renal recipients.
    Laftavi MR; Pankewycz O; Feng L; Said M; Patel S
    Immunol Invest; 2015; 44(4):373-84. PubMed ID: 25942348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prostaglandin-dependent immunoregulatory mechanism activated by in vivo administration of antithymocyte globulin.
    Thomas JM; Carver FM; Fahrenbruch GB; Hall WR; Deepe RM; Thomas FT
    Surgery; 1983 Aug; 94(2):384-91. PubMed ID: 6224306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithymocyte Globulin Antibody Titer Congruent With Kidney Transplantation: Analysis of Incidence, Outcomes, Cost, and Alternative Targets.
    Lattimore S; Skill NJ; Maluccio MA; Elliott H; Dobben E; Shafuddin A; Goggins WC
    Transplant Direct; 2019 Oct; 5(10):e493. PubMed ID: 31723588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial.
    Eason JD; Loss GE; Blazek J; Nair S; Mason AL
    Liver Transpl; 2001 Aug; 7(8):693-7. PubMed ID: 11510013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.